Onward Medical is betting that more rehab clinics adopt its ARC-EX therapy and that patients eventually use it at home, turning early interest into steadier, repeat use. The upside depends on insurance coverage and trial results for a second use case, while cash burn and changing healthcare rules could slow the rollout.Read more
Catalysts About Onward Medical Onward Medical develops neurostimulation therapies aimed at improving function and quality of life for people with spinal cord injury and related movement disabilities. What are the underlying business or industry changes driving this perspective?Read more
Catalysts About Onward Medical Onward Medical develops and commercializes neurostimulation systems intended to improve function and quality of life for people with spinal cord injury. What are the underlying business or industry changes driving this perspective?Read more
Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with spinal cord injury (SCI) in the United States, Europe, and internationally. The company offers ARCEX System, an external stimulator that is intended to improve hand strength and sensation following SCI; ARCIM System, an implantable system currently used to explore potential indications in clinical feasibility studies; ARCBCI System, an implantable system currently being investigated to enable thought driven movement of the legs and upper extremities. Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.
